Ushbu ish iqtibos qilgan ishlar

33 ta ish

Ish: Repurposing of Rutan showed effective treatment for COVID-19 disease

1. Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones

   Otávio Augusto Chaves, Natalia Fintelman‐Rodrigues, Xuanting Wang +10

   Maqola20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.258258

2. A viral arsenal

   Mitch Leslie

   Maqola20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.258260

3. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

   Yeming Wang, Dingyu Zhang, Guanhua Du +43

   Maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.581935

4. C-reactive protein and the acute phase response.

   Stanley P. Ballou, Irving Kushner

   Maqola19922 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.258221

5. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight

   Mohd Imran Khan, Zainul A. Khan, Mohammad Hassan Baig +4

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.661985

6. SARS CoV-2 SPIKE GLYCOPROTEIN MUTATIONS AND CHANGES IN PROTEIN STRUCTURE

   Ekrem Akbulut

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.661986

7. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19

   Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain +6

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.661987

8. Test No. 420: Acute Oral Toxicity - Fixed Dose Procedure

   OECD

   Kitob20022 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.661988